RT Journal Article
SR Electronic
T1 Linking private health sector to public COVID-19 response in Kisumu, Kenya: Lessons Learnt
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.29.22271489
DO 10.1101/2022.03.29.22271489
A1 M. Omollo
A1 I. A. Odero
A1 H.C. Barsosio
A1 S. Kariuki
A1 F. ter Kuile
A1 S.O. Okello
A1 K. Oyoo
A1 A. K’Oloo
A1 K. Otieno
A1 S. van Duijn
A1 S. N. Onsongo
A1 N. Houben
A1 E. Milimo
A1 R. Aroka
A1 F. Oluoch
A1 T.F. Rinke de Wit
YR 2022
UL http://medrxiv.org/content/early/2022/04/05/2022.03.29.22271489.abstract
AB Background COVID-19 is overwhelming health systems universally. Increased capacity to combat the epidemic is important, while continuing regular healthcare services. This paper describes an innovative Public Private Partnership (PPP) against COVID-19 that from the onset of the epidemic was established in Kisumu County, Western Kenya.Methods An explanatory research design was used. Qualitative in-depth interviews (n=49) were conducted with purposively selected participants including patients, health workers, and policy makers. Thematic analysis was undertaken on interview transcripts and triangulation was performed.Results The PPP hinged through the provision of central diagnostic COVID-19 services through a parastatal institute (KEMRI). Complementary tasks were divided between Kisumu Department of Health and public and private healthcare providers, supported by an NGO. Facilitators to this PPP included implementation of MoH Guidelines, digitalization of data, strengthening of counseling services and free access to COVID-19 testing services in private facilities. Barriers included, data accessibility, sub optimal financial management.Conclusion Coordinated PPP can rapidly enhance capacity and quality of COVID-19 epidemic management in African settings. Our PPP model appears scalable, as proven by current developments. Lessons learnt from this initial PPP in Kisumu County will be beneficial to expanding epidemic preparedness to other Counties in Kenya and beyond.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAchmea Foundation, NetherlandsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Scientific Ethics and Review Unit of Kenya Medical Research Institute. Centre of Global Health Research. and Ethical Review Committee of Jaramogi Oginga Odinga Teaching and Referral Hospital gave ethical approvals for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript